Taisho Pharmaceutical Holdings Co Ltd (TAIPY)
12.00
0.00 (0.00%)
USD |
OTCM |
Jun 28, 16:00
Taisho Pharmaceutical Holdings Gross Profit Margin (Quarterly): 55.61% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 55.61% |
| September 30, 2023 | 57.01% |
| June 30, 2023 | 59.75% |
| March 31, 2023 | 56.29% |
| December 31, 2022 | 60.16% |
| September 30, 2022 | 59.02% |
| June 30, 2022 | 60.53% |
| March 31, 2022 | 61.08% |
| December 31, 2021 | 62.50% |
| September 30, 2021 | 58.52% |
| June 30, 2021 | 62.20% |
| March 31, 2021 | 57.95% |
| December 31, 2020 | 63.14% |
| September 30, 2020 | 65.39% |
| June 30, 2020 | 62.92% |
| March 31, 2020 | 59.55% |
| December 31, 2019 | 58.61% |
| September 30, 2019 | 64.79% |
| June 30, 2019 | 68.45% |
| March 31, 2019 | 64.03% |
| December 31, 2018 | 64.69% |
| September 30, 2018 | 66.08% |
| June 30, 2018 | 65.57% |
| March 31, 2018 | 65.20% |
| December 31, 2017 | 66.15% |
| Date | Value |
|---|---|
| September 30, 2017 | 65.17% |
| June 30, 2017 | 64.64% |
| March 31, 2017 | 62.87% |
| December 31, 2016 | 63.73% |
| September 30, 2016 | 64.19% |
| June 30, 2016 | 63.95% |
| March 31, 2016 | 61.67% |
| December 31, 2015 | 60.08% |
| September 30, 2015 | 60.94% |
| June 30, 2015 | 61.40% |
| March 31, 2015 | 59.79% |
| December 31, 2014 | 60.60% |
| September 30, 2014 | 61.86% |
| June 30, 2014 | 63.29% |
| March 31, 2014 | 61.25% |
| December 31, 2013 | 62.80% |
| September 30, 2013 | 62.87% |
| June 30, 2013 | 62.55% |
| March 31, 2013 | 60.66% |
| December 31, 2012 | 61.48% |
| September 30, 2012 | 62.21% |
| June 30, 2012 | 62.85% |
| March 31, 2012 | 62.48% |
| December 31, 2011 | 63.84% |
| September 30, 2011 | 63.55% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
55.61%
Minimum
Dec 2023
65.39%
Maximum
Sep 2020
60.28%
Average
59.96%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 63.60% |
| Nxera Pharma Co Ltd | 74.17% |
| PeptiDream Inc | 35.00% |
| Healios KK | -- |
| AnGes Inc | 63.05% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.98% |
| Return on Assets | 0.84% |
| Return on Invested Capital | 0.98% |
| Profit Margin (Quarterly) | 3.44% |
| Operating Margin (Quarterly) | 3.18% |
| Return on Net Operating Assets | 1.61% |